| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2007 | US20070203145 Zopiclone resolution |
| 08/30/2007 | US20070203144 Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals |
| 08/30/2007 | US20070203143 such as cis-4-(4-(4-amino-3-(2-phenyl-1H-benzimidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)-1-methylpiperazin-2-one, used as anticarcinogenic agents |
| 08/30/2007 | US20070203142 Azaindoles useful as inhibitors of janus kinases |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203140 N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070203137 New Salt |
| 08/30/2007 | US20070203136 Triazolopyridazines as kinase modulators |
| 08/30/2007 | US20070203135 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists |
| 08/30/2007 | US20070203134 Benzimidazole Acetonitriles |
| 08/30/2007 | US20070203133 Substituted 5,12-diaza-benzoanthracene analogues |
| 08/30/2007 | US20070203132 2-{4-[4-(2-Ethyl-phenyl)-5-methyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl}-pyrimidine; more potent, longer duration of action, broader range of activity, more stable, fewer side effects, selectivity; anxiety, cardiovascular disease, dysmenorrhoea, endometriosis, emesis, inflammation, sexual disorders |
| 08/30/2007 | US20070203131 Bis-aryl sulfonamides |
| 08/30/2007 | US20070203130 sodium channel and calcium channel inhibitors, such as 2-Indol-1-yl-N-[5-(thiazol-2-ylsulfamoyl)-naphthalen-1-yl]-propionamide, used as analgesics or for the treatment of neurodegenerative disorders, anxiety, depression, arrhythmia, ataxia, multiple sclerosis, irritable bowel syndrome or incontinence |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070203127 Antibacterial Agents |
| 08/30/2007 | US20070203126 Synergistic Mixtures of O-Phenylphenol and Dazomet |
| 08/30/2007 | US20070203125 Medicament Combinations for the Treatment of Respiratory Diseases |
| 08/30/2007 | US20070203124 Therapeutic Piperazines |
| 08/30/2007 | US20070203123 Use of acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease |
| 08/30/2007 | US20070203122 Derivatives for modulation of ion channels |
| 08/30/2007 | US20070203121 Substituted indole compounds, their preparation and use in medicaments |
| 08/30/2007 | US20070203120 Sulfonyl Substituted 1H-Indoles as Ligands for the 5-Hydroxytryptamine Receptors |
| 08/30/2007 | US20070203119 Combination Therapy For The Treatment Of Schizophrenia |
| 08/30/2007 | US20070203118 Substituted tetrahydroisoquinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs |
| 08/30/2007 | US20070203117 modulators of nicotinic and/or of monoamine receptors; as diagnostic tools or monitoring agents; for in vivo neuroimaging in labeled/unlabelled forms; inflammation, pain, neurodegenerative disorders; cholinergic ligands;5-(4-Benzoylamino-phenyl)-furan-2-carboxylic acid(1-aza-bicyclo[2.2.2]oct-3-yl)-amide |
| 08/30/2007 | US20070203116 2'-amino-2-methoxy-1,1'-dimethyl-7-bromo-10,11-dihydrospiro[dibenzo[a,d][7]-annulene-5,4'-imidazol]-5'(1'H)-one; treatment of beta -amyloid deposits and neurofibrillary tangles; useful in treating Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy |
| 08/30/2007 | US20070203115 Novel quaternary ammonium compounds |
| 08/30/2007 | US20070203114 7,8,9,10-Tetrahydro-Imidazo [2,1-A] Isochinolines |
| 08/30/2007 | US20070203113 Use of manzamine compounds in anti-cancer therapeutic regimens |
| 08/30/2007 | US20070203112 Bladder cancer treatment and methods |
| 08/30/2007 | US20070203111 Cycloalkylamines as monoamine reuptake inhibitors |
| 08/30/2007 | US20070203110 17-Allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| 08/30/2007 | US20070203109 Compounds And Compositions For Treatment Of Cancer |
| 08/30/2007 | US20070203108 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 08/30/2007 | US20070203107 Pharmaceutical compositions |
| 08/30/2007 | US20070203106 Method for Producing 5Alpha-Pregnane Derivative |
| 08/30/2007 | US20070203105 (11 beta ,16 alpha ,17 beta )-17-cyclopropylcarbonyl-16-methyl-11-[4-(3-pyridinyl)-phenyl]estra-4,9-dien-3-one; contraception; hormone replacement therapy; endometriosis, dysmenorrhea, dysfunctional uterine bleeding and severe premenstrual syndrome |
| 08/30/2007 | US20070203104 Pharmaceutical Formulations |
| 08/30/2007 | US20070203103 Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid |
| 08/30/2007 | US20070203102 Estrogen Receptor Modulators |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 08/30/2007 | US20070203100 Immunosuppressant Compounds and Compositions |
| 08/30/2007 | US20070203099 Anionically substituted 7-nitroindoline derivatives and their uses |
| 08/30/2007 | US20070203098 Pten Inhibitors |
| 08/30/2007 | US20070203097 Fluoroquinolone carboxylic acid salt compositions |
| 08/30/2007 | US20070203096 Methyl-9-chloro-11-[2H-tetrahydropyran-2-yloxy]-17,17-tetramethylene-20-nor-5,13-prostadienoate; EP2 receptor agonists with greater selectivity and stability; reducing release of Th-1 cytokines; promoters of fertility, in vitro fertilization, ovulation, cumulus expansion; intraocular depressurization |
| 08/30/2007 | US20070203095 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| 08/30/2007 | US20070203094 alcohol groups of hyaluronic acid are esterified with rhein by reacting acid chloride of rhein with hyaluronic acid; higher stability; for treating inflammatory diseases, tissue repair, or for preparing biomaterials |
| 08/30/2007 | US20070203093 saccharide containing 3-O-.alpha.-D-glucopyranosyl-D-glucose; nigerooligosaccharide; free from side effects; atrophy of thymus due to chronic stress is treated; nigerose, nigerosylglucose and nigerosylmaltose; food or beverage |
| 08/30/2007 | US20070203091 Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging |
| 08/30/2007 | US20070203090 N-pyrazole A2A receptor agonists |
| 08/30/2007 | US20070203089 Compositions and methods for the treatment of ophthalmic disease |
| 08/30/2007 | US20070203085 Methods For Interfering With Fibrosis |
| 08/30/2007 | US20070203081 Aminoglycosides as antibiotics |
| 08/30/2007 | US20070203080 New Drug Delivery System for Crossing the Blood Brain Barrier |
| 08/30/2007 | US20070203079 Methods of using small molecule compounds for neuroprotection |
| 08/30/2007 | US20070203078 Method for the treatment and diagnosis of certain psychiatric disorders related to the menstrual cycle |
| 08/30/2007 | US20070203077 Treatment and prophylaxis of sepsis and septic shock |
| 08/30/2007 | US20070203076 Creatine ester pronutrient compounds and formulations |
| 08/30/2007 | US20070203075 Novel lactam ring-opening enzyme and use thereof |
| 08/30/2007 | US20070203074 Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
| 08/30/2007 | US20070203073 SARS and Ebola inhibitors and use thereof, and methods for their discovery |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | US20070203069 Grf-containing lyophilized pharmaceutical compositions |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070203055 Compounds and compositions for prevention of overdose of oxycodone |
| 08/30/2007 | US20070203027 5-Aminolevulinic Acid Salt, Process For Producing The Same And Use Thereof |
| 08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 08/30/2007 | US20070202598 New transfection reagents |
| 08/30/2007 | US20070202577 Method For The Production Of Hyperbranched Polysaccharide Fractions |
| 08/30/2007 | US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 08/30/2007 | US20070202574 Novel Saccharothrix Strain an Antibiotics Derived Therefrom, i.e. Mutactimycins and Aldgamycins |
| 08/30/2007 | US20070202570 Enzyme composition, low molecular weight hyaluronan and process for preparing the same |
| 08/30/2007 | US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them |
| 08/30/2007 | US20070202544 Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases |
| 08/30/2007 | US20070202524 Targeted Vectors |
| 08/30/2007 | US20070202516 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 08/30/2007 | US20070202503 Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use |
| 08/30/2007 | US20070202501 Proteins Expressed In Ink Cells |
| 08/30/2007 | US20070202499 Methylated Gene Biomarkers For Detecting Cancer |
| 08/30/2007 | US20070202212 Chewing gum containing controlled release acyclic carboxamides |
| 08/30/2007 | US20070202208 Anti-Inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity |
| 08/30/2007 | US20070202207 Use of naturally occurring epoxidised molecules from Vernonia Galamensis |
| 08/30/2007 | US20070202204 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202203 Anti-ageing composition |
| 08/30/2007 | US20070202200 Method of inhibiting weight regain after weight loss |
| 08/30/2007 | US20070202199 Compositions for Enhancing Sexual Responsiveness |
| 08/30/2007 | US20070202196 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202194 Preparation for the prevention and/or treatment of vascular disorders |
| 08/30/2007 | US20070202186 Apparatus and formulations for suprachoroidal drug delivery |
| 08/30/2007 | US20070202182 Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles |
| 08/30/2007 | US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070202180 Nanoparticulate carverdilol formulations |
| 08/30/2007 | US20070202179 Low Dose Pharmaceutical Products |
| 08/30/2007 | US20070202177 Antimicrobial Compositions and Methods for Locking Catheters |
| 08/30/2007 | US20070202175 Compressed tablet formulation containing active ingredient 4'-azidocytidine-2', 3', 5'-tri-isobutyrate hydrochloride and ethylene glycol-propylene glycol block copolymer; gel inhibition during formulation; enhanced gastrointestinal dissolution and absorption; hepatitis C virus |
| 08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |